| Performance status of patients is the major prognostic factor at all stages of pancreatic cancer F Tas, F Sen, H Odabas, L Kılıc, S Keskın, I Yıldız International journal of clinical oncology 18, 839-846, 2013 | 129 | 2013 |
| Evaluation of bevacizumab in advanced small bowel adenocarcinoma D Aydin, MA Sendur, U Kefeli, BB Ustaalioglu, O Aydin, E Yildirim, D Isik, ... Clinical Colorectal Cancer 16 (1), 78-83, 2017 | 32 | 2017 |
| Effect of port-care frequency on venous port catheter-related complications in cancer patients H Odabas, NY Ozdemir, I Ziraman, S Aksoy, H Abali, B Oksuzoglu, M Isik, ... International journal of clinical oncology 19, 761-766, 2014 | 31 | 2014 |
| Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors M Gumus, A Bilici, H Odabas, BBO Ustaalioglu, N Kandemir, U Demirci, ... World Journal of Urology 35, 1103-1110, 2017 | 23 | 2017 |
| Comparison of cisplatin-5-fluorouracil-folinic acid versus modified docetaxel-cisplatin-5-fluorouracil regimens in the first-line treatment of metastatic gastric cancer FT Kos, D Uncu, N Özdemir, B Budakoglu, H Odabaş, H Abali, ... Chemotherapy 57 (3), 230-235, 2011 | 23 | 2011 |
| Hormone receptor status and survival of medullary breast cancer patients: A Turkish cohort A Aksoy, H Odabas, S Kaya, O Bozkurt, M Degirmenci, TO Topcu, ... Saudi medical journal 38 (2), 156, 2017 | 18 | 2017 |
| Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients M Ozcelik, T Korkmaz, H Odabas, C Gemici, O Ercelep, S Yuksel, AG Mert, ... Tumor Biology 37 (7), 8901-8907, 2016 | 18 | 2016 |
| Lung cancer in women: a single institution experience with 50 patients N AKGÜL BABACAN, B YÜCEL, S Kilickap, M ŞEKER, T Kacan, ... Asian Pacific Journal of Cancer Prevention 15 (1), 2014 | 18 | 2014 |
| Gastric adenocarcinoma under the age of 40; more metastatic, less differentiated M Isik, S Caner, M Metin Seker, B Civelek, H Odabas, N Ozdemir J BUON 16 (2), 253-256, 2011 | 16 | 2011 |
| Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology A Bilici, T Ozturk, E Turkmen, H Odabas, S Cihan, F Selcukbiricik, ... World journal of urology 33, 1613-1622, 2015 | 15 | 2015 |
| Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? M Ayhan, Ş Laçin, DT Özyükseler, H Sürmeli, A Doğan, M Turan, ... Journal of Oncology Pharmacy Practice 27 (6), 1461-1467, 2021 | 12 | 2021 |
| Is there any effect of first-day usage of a totally implantable venous access device on complications? H Karanlik, H Odabas, I Yildirim, I Ozgur, B Kilic, F Sen, S Kurul, A Aydiner International journal of clinical oncology 20, 1057-1062, 2015 | 12 | 2015 |
| Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center’s experience M Ayhan, H Odabas, N Turan, DT Ozyukseler, O Kostek, G Alkan, ... Journal of Chemotherapy 33 (7), 499-508, 2021 | 11 | 2021 |
| Adjuvant modified FOLFOX-4 in patients with stage III rectum adenocarcinoma Ş Cihan, D Uncu, NA Babacan, N Özdemir, H Odabaş, S Aksoy, ... Asian Pac J Cancer Prev 12 (4), 967-970, 2011 | 11 | 2011 |
| Does proton pump inhibitors decrease the efficacy of palbociclib and ribociclib in patients with metastatic breast cancer? H Odabas, A Dogan, M Ozcelik, S Yildirim, U Ozkerim, N Turan, ... Medicina 59 (3), 557, 2023 | 10 | 2023 |
| The evaluation of foot pressure and postural structure of national golfers Hİ Odabaş, Ç Bulgan, BM Bingül, K Sarpyener Acta orthopaedica et traumatologica turcica 53 (2), 150-153, 2019 | 10 | 2019 |
| Prognostic factors of ado-trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer D Tataroglu Ozyukseler, M Basak, S Ay, A Koseoglu, S Arıcı, A Oyman, ... Journal of Oncology Pharmacy Practice 27 (3), 547-554, 2021 | 9 | 2021 |
| Genotoxic evaluation of the antibacterial drug, ciprofloxacin, in cultured lymphocytes of patients with urinary tract infection M Ikbal, H DOĞAN, H Odabaş, İ Pirim Turkish Journal of Medical Sciences 34 (5), 309-313, 2004 | 9 | 2004 |
| Diagnostic value of serum M30 and M65 in patients with nasopharyngeal carcinoma F Sen, I Yildiz, H Odabas, M Tambas, L Kilic, A Karadeniz, M Altun, ... Tumor Biology 36, 1039-1044, 2015 | 8 | 2015 |
| Pretreatment PET/CT standardized uptake values play a role in predicting response to treatment and survival in patients with small cell lung cancer N Sener Dinc, K Aydın, H Odabas, O Ercelep, G Tufan, M Seker, N Yasar, ... Oncology Research and Treatment 39 (3), 130-134, 2016 | 7 | 2016 |